C
Cyted
Biotech & Life Sciences · Cambridge, United Kingdom · Founded 2020
Unique approach combines expertise in gastrointestinal oncology, digital pathology and AI-driven biomarker discovery MoreLess
Cyted.ai is a pioneering company in the field of digital diagnostics, focusing on gastrointestinal oncology. The company leverages advanced technologies such as artificial intelligence (AI) and digital pathology to develop innovative diagnostic solutions. Cyted.ai primarily serves public and private healthcare providers, offering histopathology services, which involve the microscopic examination of tissue samples to detect diseases.
The company operates in the healthcare market, specifically targeting the early detection and monitoring of esophageal cancer and other gastrointestinal diseases. This is a critical area, as over 5 million people are diagnosed with digestive system cancers annually, with esophageal cancer being one of the deadliest due to its poor survival rates and late-stage detection.
Cyted.ai's business model revolves around providing a fast and simple test for esophageal health. This test aims to detect and monitor signs of pre-cancer and other diseases, thereby enabling earlier and less invasive diagnostics compared to traditional methods like endoscopy. By offering these advanced diagnostic services, Cyted.ai helps healthcare providers improve patient outcomes and reduce the mortality rate associated with late-stage cancer diagnoses.
The company generates revenue by offering its histopathology services to healthcare providers on a fee-for-service basis. Additionally, Cyted.ai's unique clinical pathway and data platform allow it to scale its pathology data, providing valuable insights that can further enhance patient care and streamline diagnostic processes.
In summary, Cyted.ai is transforming the healthcare landscape by providing cutting-edge diagnostic solutions that enable earlier detection and better management of gastrointestinal diseases. This not only improves patient outcomes but also addresses a significant bottleneck in the current diagnostic process.
Keywords: Digital Diagnostics, AI, Gastrointestinal Oncology, Histopathology, Esophageal Cancer, Early Detection, Healthcare Providers, Data Platform, Patient Care, Innovative Solutions.
Company overview
Cyted company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2020
- Headquarters
- Cambridge, United Kingdom
- Employees
- 73
- Open positions
- None listed
- Dealroom signal
- 85.9
Valuation & funding
Cyted funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Sep 2025 | $6M | — | British Business Bank | ↗ |
| SERIES BOther financing | Sep 2025 | $38M | $152M | Business Growth Fund · Morningside · EQT Life Sciences · Advent Life Sciences | ↗ |
| FundingOther financing | May 2024 | $0 | — | MedTech Innovator | ↗ |
| GRANTOther financing | Dec 2023 | $1.3M | — | Undisclosed | ↗ |
| EARLY VCOther financing | May 2023 | $13M | $53M | Business Growth Fund · Morningside | ↗ |
| GRANTOther financing | May 2023 | SBRI Healthcare | ↗ | ||
| EARLY VCOther financing | Feb 2022 | Undisclosed | — | ||
| GRANTOther financing | Aug 2021 | SBRI Healthcare | ↗ | ||
| GRANTOther financing | Feb 2020 | Morningside | ↗ | ||
| EARLY VCOther financing | Feb 2020 | Morningside | ↗ |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $8M | 0% | 73 |
| 2025 | $8M | 0% | 65 |
| 2024 | $8M | 0% | 57 |
| 2023 | $8M | +16.3% | 72 |
| 2022 | $6.9M | +154.8% | 61 |
| 2021 | $2.7M | — | 33 |
Growth signals
Cyted website traffic
Latest recorded traffic for Cyted is 2.2K monthly website visits, up 423.8% over the last three months. Cyted's team grew 12.3% over the past year.
Comparisons
Cyted compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Cyted's talent
Source: Dealroom Talent Intelligence.
Investors
8 investors on Cyted's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.






Global footprint
Where Cyted has talent and traffic
team presence
In the news
Latest news about Cyted
Recent press, funding announcements, and product moves mentioning Cyted — open to read from the original sources.
Market sentiment
What the market is saying about Cyted
An AI-synthesized read of the highest-engagement posts about Cyted on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cyted’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









